Prospective, Randomized, Controlled Arm Study Comparing the Coverage of the Zotarolimus-Eluting Stent vs [versus] Bare Metal Stent Implanted in ST- Elevation Myocardial Infarction (STEMI)

Trial Profile

Prospective, Randomized, Controlled Arm Study Comparing the Coverage of the Zotarolimus-Eluting Stent vs [versus] Bare Metal Stent Implanted in ST- Elevation Myocardial Infarction (STEMI)

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Jul 2013

At a glance

  • Drugs Zotarolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms OCTAMI
  • Most Recent Events

    • 12 Feb 2010 Actual number of patients (44) added as reported by ClinicalTrials.gov record.
    • 12 Feb 2010 Actual end date (1 Oct 2009) added as reported by ClinicalTrials.gov record.
    • 12 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top